← All trials
NCT04421274
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- May 1, 2008
- Primary completion
- Jul 10, 2010
- Completion date
- Jul 15, 2011
- First posted
- Jun 9, 2020
- Last posted
- Jun 9, 2020
- Enrollment
- 43
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- North Sichuan Medical UniversityLead sponsor
- Chinese Academy of Medical SciencesCollaborator
- People's Liberation Army of ChinaCollaborator
- Capital Medical UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.